carbapenems has been researched along with trimethoprim in 7 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (trimethoprim) | Trials (trimethoprim) | Recent Studies (post-2010) (trimethoprim) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 6,989 | 845 | 894 |
| Protein | Taxonomy | carbapenems (IC50) | trimethoprim (IC50) |
|---|---|---|---|
| Chain A, Dihydrofolate reductase | Bacillus anthracis | 77200 | |
| Chain A, dihydrofolate reductase (DHFR) | Bacillus anthracis | 77200 | |
| Dihydrofolate reductase | Mycobacterium avium | 0.2588 | |
| Dihydrofolate reductase | Homo sapiens (human) | 1.8206 | |
| Dihydrofolate reductase | Lacticaseibacillus casei | 0.3493 | |
| Dihydrofolate reductase type 1 | Escherichia coli | 0.25 | |
| Dihydrofolate reductase | Neisseria gonorrhoeae | 0.45 | |
| Thymidylate synthase | Homo sapiens (human) | 3.405 | |
| Dihydrofolate reductase | Staphylococcus aureus | 0.0875 | |
| Thymidylate synthase | Escherichia coli K-12 | 3.405 | |
| Dihydrofolate reductase | Escherichia coli K-12 | 0.6064 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.01 | |
| Dihydrofolate reductase type 1 from Tn4003 | Staphylococcus aureus | 0.023 | |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | 2.7 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.7061 | |
| Dihydrofolate reductase | Candida albicans | 0.1361 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 2.7 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.45 | |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | 2.73 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 2.8 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 3.2206 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium berghei ANKA | 0.12 | |
| Dihydrofolate reductase | Streptococcus pneumoniae TIGR4 | 0.0297 | |
| Dihydrofolate reductase | Lactococcus lactis subsp. lactis Il1403 | 0.45 | |
| Dihydrofolate reductase | Bacillus anthracis | 4.77 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 1.244 | |
| Dihydrofolate reductase | Pneumocystis jirovecii | 0.092 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Curty, LK; Epp, SF; Köhler, T; Pechère, JC | 1 |
| De Smet, B; Jacobs, J; Kham, C; Koole, O; Kruy, L; Lynen, L; Phe, T; Thai, S; Veng, CH; Vlieghe, E | 1 |
| Dance, D | 1 |
| Bao, M; Fu, Y; Li, C; Su, S; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, Y | 1 |
| Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD | 1 |
| Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K | 1 |
| Aiesh, BM; Maali, Y; Omarya, S; Qandeel, F; Sabateen, A; Sholi, S; Taha, AA; Taha, SA; Zyoud, SH | 1 |
1 review(s) available for carbapenems and trimethoprim
| Article | Year |
|---|---|
Treatment and prophylaxis of melioidosis.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim | 2014 |
6 other study(ies) available for carbapenems and trimethoprim
| Article | Year |
|---|---|
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.
Topics: 4-Quinolones; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Carbapenems; Chloramphenicol; Cloning, Molecular; Drug Resistance, Multiple; Gene Expression Regulation, Bacterial; Genes, Bacterial; Molecular Sequence Data; Mutation; Operon; Phenotype; Porins; Pseudomonas aeruginosa; RNA Processing, Post-Transcriptional; Sequence Analysis, DNA; Transcription, Genetic; Trimethoprim | 1999 |
Melioidosis, phnom penh, Cambodia.
Topics: Adolescent; Adult; Aged; Burkholderia pseudomallei; Cambodia; Carbapenems; Cephalosporins; Diabetes Mellitus, Type 2; Diagnostic Errors; Doxycycline; Female; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Sulfamethoxazole; Survival Rate; Trimethoprim | 2011 |
Outbreak of KPC-2-Producing
Topics: Adhesins, Bacterial; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gene Expression; Genome, Bacterial; Hospital Units; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neurosurgery; Plasmids; Sulfonamides; Trimethoprim; Whole Genome Sequencing | 2020 |
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Chronic Disease; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfadoxine; Trimethoprim; United States; Urinary Tract Infections | 2021 |
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections | 2022 |
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Developing Countries; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Retrospective Studies; Sulfamethoxazole; Tertiary Care Centers; Trimethoprim | 2023 |